Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020-December 2020

Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S54-S57. doi: 10.1093/cid/ciab309.

Abstract

Repeating the BinaxNOW antigen test for severe acute respiratory syndrome coronavirus 2 using 2 groups of readers within 30 minutes resulted in high concordance (98.9%) in 2110 encounters. Same-day repeat antigen testing did not significantly improve test sensitivity (77.2% to 81.4%) while specificity remained high (99.6%).

Keywords: BinaxNOW; COVID-19; SARS-CoV-2; antigen testing; diagnostic performance.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • COVID-19 Testing
  • COVID-19*
  • Humans
  • SARS-CoV-2*
  • Sensitivity and Specificity
  • Wisconsin / epidemiology

Grants and funding